Alliancebernstein L.P. Eli Lilly & CO Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Alliancebernstein L.P. holds 4,787,574 shares of LLY stock, worth $3.93 Billion. This represents 1.35% of its overall portfolio holdings.

Number of Shares

4,787,574

Previous 5,062,301 5.43%

Holding current value

$3.93 Billion

Previous $2.95 Billion 26.22%

% of portfolio

1.35%

Previous 1.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $163 Million - $218 Million	-274,727 Reduced 5.43%	4,787,574 $3.72 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $77.1 Million - $90.8 Million	146,722 Added 2.98%	5,062,301 $2.95 Billion
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $78.8 Million - $109 Million	181,351 Added 3.83%	4,915,579 $2.64 Billion
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $63.4 Million - $84.8 Million	180,714 Added 3.97%	4,734,228 $2.22 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $798 Million - $937 Million	2,568,469 Added 129.39%	4,553,514 $1.56 Billion

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $44.8 Million - $52.2 Million	-139,254 Reduced 6.56%	1,985,045 $726 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $17 Million - $19.4 Million	57,286 Added 2.77%	2,124,299 $687 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $26.7 Million - $31.4 Million	95,909 Added 4.87%	2,067,013 $670 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $15 Million - $18.6 Million	-63,813 Reduced 3.14%	1,971,104 $564 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $28 Million - $34.7 Million	-124,357 Reduced 5.76%	2,034,917 $562 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $27.1 Million - $33.4 Million	122,425 Added 6.01%	2,159,274 $499 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $21.8 Million - $28.2 Million	120,812 Added 6.31%	2,036,849 $467 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $71 Million - $91.9 Million	-431,859 Reduced 18.39%	1,916,037 $358 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $21 Million - $27.7 Million	-160,623 Reduced 6.4%	2,347,896 $396 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $13 Million - $15.1 Million	-89,206 Reduced 3.43%	2,508,519 $371 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $11.6 Million - $13.9 Million	-84,883 Reduced 3.16%	2,597,725 $426 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $128 Million - $159 Million	-1,078,646 Reduced 28.68%	2,682,608 $372 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $124 Million - $153 Million	-1,155,529 Reduced 23.5%	3,761,254 $494 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $50 Million - $54.4 Million	468,455 Added 10.53%	4,916,783 $550 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $134 Million - $156 Million	1,205,957 Added 37.19%	4,448,328 $493 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $81.2 Million - $95.5 Million	729,098 Added 29.01%	3,242,371 $421 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $18.9 Million - $21.2 Million	-178,395 Reduced 6.63%	2,513,273 $291 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $34.9 Million - $43.7 Million	-406,909 Reduced 13.13%	2,691,668 $289 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $4.38 Million - $5.03 Million	57,850 Added 1.9%	3,098,577 $264 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $97.3 Million - $115 Million	-1,310,932 Reduced 30.12%	3,040,727 $235 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $29.9 Million - $32.1 Million	365,011 Added 9.16%	4,351,659 $368 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $307 Million - $341 Million	3,986,648	3,986,648 $341 Million

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Eli Lilly & CO Transaction History